Hexagon Nutrition IPO
FMCG • ₹138.87 Cr
Medium risk because:
- 5 material risk factors disclosed in DRHP
- Heavy dependence on government or PSU customers
- Regulatory or legal risks cited in DRHP
IPOFins risk score from DRHP risk factors, subscription demand & issue structure
Price Band
₹45
Lot Size
333 shares
Issue Size
₹138.87 Cr
Open
05 Jun 2026
Close
09 Jun 2026
Subscription
52.5×
IPO Schedule
| Issue Open Date | 05 Jun 2026 |
| Issue Close Date | 09 Jun 2026 |
| Listing Date | 11 Jun 2026 |
About Hexagon Nutrition
Hexagon Nutrition is a research-oriented nutrition company engaged in the development, manufacturing, and marketing of a diversified portfolio of nutrition and wellness products. The company operates across multiple segments, including branded wellness and clinical nutrition products, premix formulations, and therapeutic nutrition solutions such as ready-to-use foods (RUFs) and micronutrient powders (MNPs). Established in 1993, the company initially operated as a micronutrient formulations player and subsequently expanded into branded health and clinical nutrition products. Hexagon Nutrition operates manufacturing facilities in Maharashtra, Tamil Nadu, and Uzbekistan, with two Indian facilities located in Special Economic Zones (SEZs). The company exports its products to more than 75 countries and serves domestic and international FMCG companies, healthcare organisations, and public health programmes. Its operations are supported by integrated manufacturing processes and certifications, including FSSC 22000, GMP, and ISO 9001:2015.
Company Details
Founders / Promoters
Mr Vikram Arun Kelkar
Founded
1993
Registrar
KARVY
Documents
DRHP / RHP Document (PDF)
View official prospectus →
Investment Analysis
Hexagon Nutrition — IPOFins Verdict
QuantitativeDriven by QIB demand at 19.8x and moderate disclosed risk (5/10), Hexagon Nutrition listed at a premium of 7.2% to its issue price. The signals lean constructive — still confirm valuation against listed peers and read the DRHP before applying beyond one lot.
- The company claims to operate as a fully integrated nutrition player with presence across the entire value chain, including research and development (R&D), manufacturing, quality assurance, regulatory
- The company claims to have established recognised nutrition brands such as ‘PENTASURE,’ ‘OBESIGO,’ ‘PEDIAGOLD,’ and ‘NUTRONE,’ catering to wellness, weight management, pediatric, and clinical nutritio
- The company claims to have developed long-standing relationships with customers across its B2C, B2B2C, and ESG segments through consistent product quality, customised solutions, and timely delivery. D
- The company claims to operate two in-house R&D centres located in Nasik and Chennai, supported by a team of qualified professionals. The company states that its R&D capabilities enable the development
- The company claims to operate four manufacturing facilities, including three in India and one in Uzbekistan, supported by advanced machinery and automated production systems. Two of its Indian facilit
Score breakdown — what drove this verdict
Moderate risk from DRHP → score +0.0
Institutional subscription → score +2.0
Strong retail interest → score +0.5
Actual listing outcome → score +0.5
Base score: 5.0 · Final score = base + all factor adjustments, capped 1–10. Full methodology →
IPOFins Score is a quantitative signal from subscription demand, disclosed risk, and listing data — not investment advice. Not SEBI-registered.
Listing Performance
Issue Price
₹45
Listing Price
₹48.25
Listing Gain/Loss
+7.22%
Listing Date
11 Jun 2026
Price Since Listing
Returns are measured against the ₹45 issue price.
Listing
₹48.25
+7.2%
1 Week
₹50.93
+13.2%
1 Month
₹71.75
+59.4%
Current
₹60.95
+35.4%
Want to buy this stock?
Trade Hexagon Nutrition on the secondary market
FAQ
What is the price band of Hexagon Nutrition IPO?
The price band is ₹45 per share with a lot size of 333 shares. Minimum investment: ₹14,985.
What does Hexagon Nutrition do?
Hexagon Nutrition is a research-oriented nutrition company engaged in the development, manufacturing, and marketing of a diversified portfolio of nutrition and wellness products. The company operates across multiple segments, including branded wellness and clinical nutrition products, premix formulations, and therapeutic nutrition solutions such as ready-to-use foods (RUFs) and micronutrient powders (MNPs). Established in 1993, the company initially operated as a micronutrient formulations player and subsequently expanded into branded health and clinical nutrition products. Hexagon Nutrition operates manufacturing facilities in Maharashtra, Tamil Nadu, and Uzbekistan, with two Indian facilities located in Special Economic Zones (SEZs). The company exports its products to more than 75 countries and serves domestic and international FMCG companies, healthcare organisations, and public health programmes. Its operations are supported by integrated manufacturing processes and certifications, including FSSC 22000, GMP, and ISO 9001:2015.
Should I apply for Hexagon Nutrition IPO?
Hexagon Nutrition listed at ₹48.25 (+7.2% premium to the ₹45 issue price) after 52.5x subscription. IPOFins Score 8/10: Driven by QIB demand at 19.8x and moderate disclosed risk (5/10), Hexagon Nutrition listed at a premium of 7.2% to its issue price. The signals lean constructive — still confirm valuation against listed peers and read the DRHP before applying beyond one lot.
Who founded Hexagon Nutrition?
Hexagon Nutrition was founded by Mr Vikram Arun Kelkar in 1993.